Lisa M Vann

Learn More
BACKGROUND Current treatments for pulmonary arterial hypertension (PAH) have been shown to improve dyspnea, 6-min walk distance (6MWD), and pulmonary hemodynamics, but few studies were designed to compare treatment regimens or assess the impact of treatment on mortality. METHODS We conducted a systematic review to evaluate the comparative effectiveness(More)
  • 1